1. Home
  2. RMCF vs FEMY Comparison

RMCF vs FEMY Comparison

Compare RMCF & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocky Mountain Chocolate Factory Inc.

RMCF

Rocky Mountain Chocolate Factory Inc.

HOLD

Current Price

$0.94

Market Cap

14.9M

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$3.91

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMCF
FEMY
Founded
1981
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.9M
12.0M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
RMCF
FEMY
Price
$0.94
$3.91
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
170.0K
35.0K
Earning Date
06-16-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
34.88
44.71
EPS
N/A
N/A
Revenue
$30,432,352.00
$2,293,313.00
Revenue This Year
N/A
$105.16
Revenue Next Year
N/A
$200.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.77
52 Week Low
$0.84
$0.29
52 Week High
$2.99
$6.29

Technical Indicators

Market Signals
Indicator
RMCF
FEMY
Relative Strength Index (RSI) 31.43 57.80
Support Level $0.84 $0.48
Resistance Level $1.19 $4.78
Average True Range (ATR) 0.09 0.42
MACD 0.01 -0.15
Stochastic Oscillator 13.93 54.38

Price Performance

Historical Comparison
RMCF
FEMY

About RMCF Rocky Mountain Chocolate Factory Inc.

Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The company prepares numerous products, including caramel apples in the store. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, and Others. The company derives maximum revenue through manufacturing activities. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: